PARP4 and ovarian carcinoma: Despite their suppressive role, PARP4 expression is also associated with resistance to cisplatin treatment, as evidenced by the restoration of sensitivity in resistant ovarian cancer cells following PARP4 silencing with small interfering RNA (siRNA) [54,55].